ITEMS IN AFP WITH KEYWORD:

Deep Venous Thrombosis

Apr 1, 2015 Issue
Thrombolysis for DVT: Has the Time Arrived? [AFP Journal Club]

Catheter-directed thrombolysis for proximal DVT is experimental but may be considered in a patient with phlegmasia and resulting compartment syndrome.


Mar 1, 2015 Issue
Risk of Venous Thromboembolism with Use of Combined Oral Contraceptives [Cochrane for Clinicians]

All combined oral contraceptives increase VTE risk. The risk is greater for those containing desogestrel, drospirenone, gestodene (not available in the United States), and cyproterone acetate (not available in the United States) when compared with levonorgestrel. All combined oral contraceptives are effective in preventing pregnancy.


Dec 1, 2013 Issue
Aspirin Is as Safe and Effective as LMWH for Extended Thromboprophylaxis After Total Hip Arthroplasty [POEMs]

Aspirin is as effective as dalteparin for extended thromboprophylaxis in patients who had total hip arthroplasty and had initially received 10 days of dalteparin prophylaxis postoperatively. Because of its relative safety, low cost, and easy administration, aspirin is an attractive alternative to lo...


Sep 1, 2013 Issue
D-dimer vs. Ultrasonography for DVT: Use Prediction Rule [POEMs]

Use the Wells criteria to determine the likelihood of deep venous thrombosis; patients at moderate to high risk should go straight to ultrasonography. Patients at low risk should have d-dimer testing, followed by ultrasonography only if the results are positive. This approach decreases the use of d-...


Jun 1, 2013 Issue
Aspirin Following Anticoagulation Therapy Prevents Recurrent VTE [POEMs]

Although this ASPIRE study was underpowered to detect a difference in the primary outcome, when the results were combined with those of the WARFASA trial, the data show that daily low-dose aspirin prevents recurrent VTE as well as major vascular events without increasing bleeding in patients who hav...


Apr 15, 2013 Issue
Updated Guidelines on Outpatient Anticoagulation [Article]

The American College of Chest Physicians provides recommendations for the use of anticoagulant medications for several indications that are important in the primary care setting. Warfarin, a vitamin K antagonist, is recommended for the treatment of venous thromboembolism and for the prevention of st...


Nov 15, 2012 Issue
Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism [Article]

Venous thromboembolism manifests as deep venous thrombosis (DVT) or pulmonary embolism, and has a mortality rate of 6 to 12 percent. Well-validated clinical prediction rules are available to determine the pretest probability of DVT and pulmonary embolism. When the likelihood of DVT is low, a negativ...


Oct 15, 2012 Issue
Rivaroxaban (Xarelto) for Prevention of Thromboembolic Events [STEPS]

In patients at high risk of stroke because of nonvalvular atrial fibrillation, rivaroxaban is as safe and effective as warfarin. However, it should not be used in patients at risk of stroke for reasons other than nonvalvular atrial fibrillation until research shows its relative safety and effectiveness.


Jun 15, 2012 Issue
ACP Recommendations for VTE Prophylaxis in Hospitalized Patients [Practice Guidelines]

Most hospitalized patients have at least one risk factor for venous thromboembolism (VTE), such as pulmonary embolism or deep venous thrombosis. The American College of Physicians (ACP) has released guidelines on VTE prophylaxis in hospitalized, nonsurgical patients, including those with acute stroke.


Jan 15, 2012 Issue
Thromboembolism [Clinical Evidence Handbook]

What are the effects of treatments for proximal and isolated calf DVT? What are the effects of treatments for pulmonary embolism? What are the effects of interventions on oral anticoagulation management in persons with thromboembolism?


Pages: Previous 1 2 3 4 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now